United Nations Moving Ahead On Consolidation of AIDS Programs

The program, called the Joint and Co-Sponsored U.N. Program on HIV/AIDS, was first proposed by the World Health Organization's (WHO) executive board of directors in January of this year. It was given final approval by the U.N. Economic and Social Council last month. Expected to be fully functional by January 1996, the program would link AIDS-related activities of six participating organizations: WHO; the World Bank; the U.N. Educati

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The program, called the Joint and Co-Sponsored U.N. Program on HIV/AIDS, was first proposed by the World Health Organization's (WHO) executive board of directors in January of this year. It was given final approval by the U.N. Economic and Social Council last month. Expected to be fully functional by January 1996, the program would link AIDS-related activities of six participating organizations: WHO; the World Bank; the U.N. Educational, Scientific, and Cultural Organization (UNESCO); the U.N. Development Program (UNDP); the U.N. International Children's Emergency Fund (UNICEF); and the U.N. Fund for Population (UNFP). Researchers and others involved in the consolidation envision the program as a central resource to which members of the six participating organizations can turn for funding and guidance in both policy and scientific research.

"What this [program] means is that the results from the research can be more readily and immediately applied where they are urgently needed," says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Neeraja Sankaran

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide